Ophthalmology Real-World Data

Quality Ophthalmology Real-world Data Only Found Here.
Curated from the IRIS Registry from 15,000 Contributing Clinicians.

Ophthalmology Qdata is a collection of research ready data modules. Electronic health record (EHR) data from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) is linked with other data sources including ophthalmic images and claims data to support your needs from clinical trials through to commercialization.

Download Datasheet

Talk to a Qdata Expert

About Ophthalmology Qdata®

Verana Health’s Qdata modules are research ready and fit-for-purpose, designed to inform research outcomes and drive business insights. By providing ophthalmology real-world data to inform real-world evidence, Qdata can help unlock quality insights across the entire drug and device development cycle.

The use of unstructured, real-world data can expand medical research by providing a wider population of patients with ophthalmic conditions. Leveraging unstructured data, clinical notes from EHRs, more patients can be identified for research based on clinical characteristics or patient outcomes beyond what may live in structured diagnosis or treatment codes. Clinical trials are often limited in the type of patients they can support, meaning researchers may miss out on potential patients. Real-world data can help support studies regarding burden of disease, treatment patterns and outcomes, or even details regarding therapy usage down to the brand level.

By providing real-world data to CROs, and life sciences companies, our Qdata modules can pave the way for better research and better treatment options in the future.

Learn More About Qdata

Qdata for Ophthalmology Research

New research ready ophthalmology real-world data modules are continuously in development. Check back for updates.

Qdata Available

Anti-VEGF Market Tracker

Verana Health’s Anti-VEGF Market Tracker provides real-world data of anti-VEGF treatments for patients with retinal conditions down to the brand level.

Geographic Atrophy (GA)

Key variables include GA Diagnosis, visual acuity, lesion location, lesion growth rate, and lesion size, perimeter, and count.

Cataracts

Key variables include visual acuity , intraocular pressure (IOP) reading and intraocular lens (IOL) brand/model

Wet Age-related Macular Degeneration (nAMD)

Qdata provides key variables extracted from EHR data, including visual acuity and central subfield thickness (CST).

Glaucoma

Key variables include intraocular pressure (IOP), MIGS device brand, visual acuity, and Medication.

Retinitis Pigmentosa

Visual acuity and central subfield thickness are key variables curated from semi-structured fields

Dry Age-related Macular Degeneration (dAMD)

Key variables extracted from EHR data for this condition include Visual Acuity and geographic atrophy diagnosis.

Thyroid Eye Disease (TED)

Key variables include confirmation of TED from clinical notes, visual acuity, clinical activity score, and TED disease severity.

Diabetic Retinopathy (DR)

Key variables include visual Acuity and central Subfield Thickness (CST).

Uveitic Macular Edema (UME)

Key variables include visual acuity and central subfield thickness (CST).

Diabetic Macular Edema (DME)

Key variables include visual acuity and central subfield thickness (CST).

Dry Eye Disease

Key variables include Schirmer's test and tear break-up time (TBUT)

Qdata in Development

Retinal Vein Occlusion (RVO)

Other Ophthalmic Conditions

Verana Health can work with Life Sciences companies to create Qdata modules that are fit for specific research purposes on select diseases or therapies.

Data to Meet Your Team’s Needs

Select Qdata modules* are available via:

*Subject to Qdata module readiness and are dependent on project scope and feasibility

Meet with a Qdata Expert or Request a Data Count

Schedule Now

IRIS Registry: By the Numbers

Verana Health is the exclusive data curation and analytics partner for the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight).